Hawaii HB92, HB882 and SB585 would effectively nullify some FDA restrictions on terminally ill patients. HB92 and HB882 must pass through the House Health Committee successfully, and SB585 must pass through the Senate Health Committee successfully before the bills can receive full votes in their respective chambers. Take the following action steps to support these important bills.
FOR HB92 & HB882
1. Call the House Health Committee Chair, Della Au Belatti. Strongly, but respectfully urge her to move HB92 & HB882 forward to a vote in her committee. A phone call has 10x the impact of an email.
808-586-9425
2. Call the rest of the committee members. Again, be strong, but respectful. Urge each of them to take action to move the bills forward and vote YES on HB92 & HB882.
Richard Creagan (D) Vice Chair 808-586-9605
Mark Hashem (D) 808-586-6510
Jo Jordan (D) 808-586-8460
Bertrand Kobayashi (D) 808-586-6310
Dee Morikawa (D) 808-586-6280
Marcus Oshiro (D) 808-586-6700
Beth Fukumoto Chang (R) 808-586-9460
Andria Tupola (R) 808-586-8465
FOR SB149
1. Call the Senate Health Committee Chair, Josh Green. Strongly, but respectfully urge him to move SB149 forward to a vote in his committee. A phone call has 10x the impact of an email.
808-586-9385
2. Call the rest of the committee members. Again, be strong, but respectful. Urge each of them to take action to move the bill forward and vote YES on SB149.
Glenn Wakai (D) Vice Chair 808-586-8585
Rosalyn Baker (D) 808-586-6070
Mike Gabbard (D) 808-586-6830
Gil Riviere (D) 808-586-7330
Russell Ruderman (D) 808-586-6890
Sam Slom (R) 808-586-8420
-Call Back – any NO or UNDECIDED – in 3-4 days. Make sure to follow-up. If they say YES, be sure to thank them and, if possible, announce their committed YES vote to email and social media contacts. If they say no, politely ask them why. Get the information from them and contact us.
-Spread the Word. Share this information widely by facebook, twitter, email and other social networks.
-Report Back. Tell us how your actions went. Click the button below
